COMPARISON OF INTRAVENOUS AND ORAL VERAPAMIL DOSING

被引：72

作者：

REITER, MJ

SHAND, DG

PRITCHETT, ELC

机构：

[1] DUKE UNIV,MED CTR,DEPT MED,DIV CARDIOL,DURHAM,NC 27710

[2] DUKE UNIV,MED CTR,DEPT PHARMACOL,DIV CLIN PHARMACOL,DURHAM,NC 27710

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1982年 / 32卷 / 06期

关键词：

D O I：

10.1038/clpt.1982.227

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：711 / 720

页数：10

共 22 条

[1] EFFECTS OF VERAPAMIL ON P-R-INTERVALS IN RELATION TO VERAPAMIL PLASMA-LEVELS FOLLOWING SINGLE IV AND ORAL-ADMINISTRATION AND DURING CHRONIC TREATMENT
EICHELBAUM, M
BIRKEL, P
GRUBE, E
GUTGEMANN, U
SOMOGYI, A
[J]. KLINISCHE WOCHENSCHRIFT, 1980, 58 (18): : 919 - 925
[2] GALEAZZI RL, 1976, CLIN PHARMACOL THER, V20, P278
[3] RAPID HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ANALYSIS OF VERAPAMIL IN BLOOD AND PLASMA
HARAPAT, SR
KATES, RE
[J]. JOURNAL OF CHROMATOGRAPHY, 1979, 170 (02): : 385 - 390
[4] VERAPAMIL DISPOSITION KINETICS IN CHRONIC ATRIAL-FIBRILLATION
KATES, RE
KEEFE, DLD
SCHWARTZ, J
HARAPAT, S
KIRSTEN, EB
HARRISON, DC
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (01) : 44 - 51
[5] COMPARISON OF THE ELECTROPHYSIOLOGIC EFFECTS OF INTRAVENOUS AND ORAL VERAPAMIL IN PATIENTS WITH PAROXYSMAL SUPRA-VENTRICULAR TACHYCARDIA
KLEIN, GJ
GULAMHUSEIN, S
PRYSTOWSKY, EN
CARRUTHERS, SG
DONNER, AP
KO, PT
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (01) : 117 - 124
[6] KOIKE Y, 1979, RES COMMUN CHEM PATH, V24, P37
[7] KRIKLER D, 1974, EUR J CARDIOL, V2, P3
[8] ORAL VERAPAMIL FOR PAROXYSMAL SUPRA-VENTRICULAR TACHYCARDIA - A LONG-TERM, DOUBLE-BLIND RANDOMIZED TRIAL
MAURITSON, DR
WINNIFORD, MD
WALKER, WS
RUDE, RE
CARY, JR
HILLIS, LD
[J]. ANNALS OF INTERNAL MEDICINE, 1982, 96 (04) : 409 - 412
[9] THE PHARMACOLOGY OF VERAPAMIL .4. KINETIC AND DYNAMIC EFFECTS AFTER SINGLE INTRAVENOUS AND ORAL DOSES
MCALLISTER, RG
KIRSTEN, EB
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (04) : 418 - 426
[10] REITER MJ, AM J CARDIOL

← 1 2 3 →